+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Prurigo Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768151
  • Report
  • 48 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Celerion Inc
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • Faes Farma SA
  • GlaxoSmithKline Plc
  • Menlo Therapeutics Inc
  • MORE
The global clinical trial report- “2019 Prurigo Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Prurigo. It presents in-depth analysis of Prurigo clinical trials across markets and companies. The research work is for providing complete understanding into trends in Prurigo.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Prurigo clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Prurigo

The research work is prepared through extensive and continuous research on Prurigo trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Prurigo patients are identified
  • The report includes panorama of Prurigo clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Prurigo clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Celerion Inc
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • Faes Farma SA
  • GlaxoSmithKline Plc
  • Menlo Therapeutics Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Prurigo Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Prurigo Clinical Trials by Region
2.2.2 Average Enrollment of Prurigo Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Prurigo Treatment, 2019

3. Region wise Prurigo Clinical Trials
3.1 Asia Pacific Prurigo Clinical Trials by Country
3.2 Europe Prurigo Clinical Trials by Country
3.3 North America Prurigo Clinical Trials by Country
3.4 Middle East and Africa Prurigo Clinical Trials by Country
3.5 South and Central America Prurigo Clinical Trials by Country

4. Prurigo Clinical Trial Trends
4.1 Start Year wise Prurigo Clinical Trials
4.2 Phase wise Prurigo Clinical Trials
4.3 Trial Status wise Prurigo Clinical Trials
4.4 Trial Type wise Prurigo Clinical Trials

5. Prurigo Average Enrollment Trends
5.1 Average Enrollment in Prurigo Trials by Year
5.2 Average Enrollment in Prurigo Trials by Phase
5.3 Average Enrollment in Prurigo Trials by Status
5.4 Average Enrollment in Prurigo Trials by Type of Trial

6. Companies Participating in Prurigo Clinical Trials
6.1 Prurigo Trials by Sponsor Type
6.2 Prurigo Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Prurigo Trials- Phase 1
7.2 Prurigo Trials- Phase 2
7.3 Prurigo Trials- Phase 3
7.4 Prurigo Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Prurigo Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Prurigo Clinical Trials and Enrolment
Figure 5: Europe - Country wise Prurigo Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Prurigo Clinical Trials and Enrolment
Figure 7: North America - Country wise Prurigo Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Prurigo Clinical Trials and Enrolment
Figure 9: Prurigo Clinical Trials by Phase
Figure 10: Prurigo Clinical Trials by Trial Status
Figure 11: Prurigo Clinical Trials by Type
Figure 12: Prurigo Clinical Trials by Sponsor Type
Figure 13: Prurigo Clinical Trials by Leading Sponsors
Figure 14: Prurigo Average Enrollment by Phase
Figure 15: Prurigo Average Enrollment by Trial Status
Figure 16: Prurigo Average Enrollment by Type
Figure 17: Prurigo- Average Enrolment by Type of Sponsors
Figure 18: Prurigo- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Prurigo Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Prurigo Clinical Trials and Enrolment
Table 5: Europe - Country wise Prurigo Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Prurigo Clinical Trials and Enrolment
Table 7: North America - Country wise Prurigo Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Prurigo Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Prurigo Average Enrollment by Phase
Table 15: Prurigo Average Enrollment by Trial Status
Table 16: Prurigo Average Enrollment by Type
Table 17: Prurigo- Average Enrolment by Type of Sponsors
Table 18: Prurigo- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • C. H. Boehringer Sohn AG & Co KG
  • Celerion Inc
  • Celgene Corp
  • Charles River Laboratories International Inc
  • F. Hoffmann-La Roche Ltd
  • Faes Farma SA
  • GlaxoSmithKline Plc
  • Menlo Therapeutics Inc
  • Trevi Therapeutics Inc
  • UCB SA
Note: Product cover images may vary from those shown
Adroll
adroll